BioSpace News Archive

RELIEF THERAPEUTICS Holding SA reported that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., has announced it has filed for a new Breakthrough Therapy Designation request with the U.S. FDA focused on patients with Critical COVID-19 and respiratory failure who are at immediate risk of death despite treatment with Remdesivir and other approved therapies.

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with SequMed, a pioneer in single-cell omics technology innovation and applications in China.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that Elizabeth Mora was elected as Board Chairperson.

ProQR Therapeutics N.V. today announced that it has amended its convertible debt financing agreement entered into in 2020 with Kreos Capital (“Kreos”) and Pontifax Medison Debt Financing (“Pontifax”).

Recently, Morgan Stanley Capital International (MSCI), the world’s largest index provider, has updated the Environmental, Social and Governance (ESG) rating of China Medical System Holdings Limited (“CMS” or the “Company”).